FIC20190031I1 - Rifamysiini SV - Google Patents
Rifamysiini SVInfo
- Publication number
- FIC20190031I1 FIC20190031I1 FIC20190031C FIC20190031C FIC20190031I1 FI C20190031 I1 FIC20190031 I1 FI C20190031I1 FI C20190031 C FIC20190031 C FI C20190031C FI C20190031 C FIC20190031 C FI C20190031C FI C20190031 I1 FIC20190031 I1 FI C20190031I1
- Authority
- FI
- Finland
- Prior art keywords
- rifamycin
- colon
- antimicrobial
- infections
- treatment
- Prior art date
Links
- HJYYPODYNSCCOU-ZDHWWVNNSA-N Rifamycin SV Natural products COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)C)cc(O)c4c3C2=O HJYYPODYNSCCOU-ZDHWWVNNSA-N 0.000 title 1
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical compound OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 title 1
- 229940109171 rifamycin sv Drugs 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000002924 anti-infective effect Effects 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 210000002429 large intestine Anatomy 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001295A ITMI20041295A1 (it) | 2004-06-25 | 2004-06-25 | Composizioni farmaceutiche antimicrobiche orali |
| PCT/EP2005/052025 WO2006003043A1 (en) | 2004-06-25 | 2005-05-03 | Oral antimicrobial pharmceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FIC20190031I1 true FIC20190031I1 (fi) | 2019-05-28 |
Family
ID=34968899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIC20190031C FIC20190031I1 (fi) | 2004-06-25 | 2019-05-28 | Rifamysiini SV |
Country Status (22)
| Country | Link |
|---|---|
| US (9) | US8486446B2 (enExample) |
| EP (2) | EP1894560A1 (enExample) |
| JP (2) | JP5026262B2 (enExample) |
| KR (2) | KR101157486B1 (enExample) |
| CN (2) | CN1976685B (enExample) |
| AT (1) | ATE392889T1 (enExample) |
| CA (2) | CA2569683C (enExample) |
| CY (1) | CY1108196T1 (enExample) |
| DE (1) | DE602005006278T2 (enExample) |
| DK (1) | DK1763339T3 (enExample) |
| ES (1) | ES2303255T3 (enExample) |
| FI (1) | FIC20190031I1 (enExample) |
| HR (1) | HRP20080252T3 (enExample) |
| HU (1) | HUS1900037I1 (enExample) |
| IT (1) | ITMI20041295A1 (enExample) |
| MX (1) | MXPA06014698A (enExample) |
| PL (1) | PL1763339T3 (enExample) |
| PT (1) | PT1763339E (enExample) |
| RS (1) | RS50581B (enExample) |
| SI (1) | SI1763339T1 (enExample) |
| WO (1) | WO2006003043A1 (enExample) |
| ZA (1) | ZA200610577B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| PL2011486T5 (pl) † | 2007-07-06 | 2016-09-30 | Lupin Ltd | Farmaceutyczne kompozycje rifaksyminy |
| WO2009037264A2 (en) * | 2007-09-17 | 2009-03-26 | Da Volterra | Colonic delivery of antimicrobial agents |
| US8470885B2 (en) | 2009-01-12 | 2013-06-25 | Biokier, Inc. | Composition and method for treatment of diabetes |
| US9314444B2 (en) | 2009-01-12 | 2016-04-19 | Biokier, Inc. | Composition and method for treatment of NASH |
| US9006288B2 (en) | 2009-01-12 | 2015-04-14 | Biokier, Inc. | Composition and method for treatment of diabetes |
| WO2010144865A2 (en) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| MX2012003459A (es) | 2009-09-23 | 2012-05-22 | Biokier Inc | Composicion y metodo para el tratamiento de la diabetes. |
| WO2012016707A2 (en) * | 2010-08-06 | 2012-02-09 | Ratiopharm Gmbh | Oral dosage form for the modified release of dimebolin |
| US20130259947A1 (en) * | 2010-11-29 | 2013-10-03 | Dr. Reddy's Laboratories Ltd. | Oral metronidazole pharmaceutical compositions |
| EP4438039A3 (en) * | 2017-11-10 | 2024-12-04 | Cosmo Technologies Ltd. | Oral rifamycin sv compositions |
| IT202000005782A1 (it) | 2020-03-18 | 2021-09-18 | Dpl Pharma S P A | Formulazioni farmaceutiche a rilascio controllato per il trattamento di infezioni intestinali |
| KR102714380B1 (ko) * | 2021-06-09 | 2024-10-11 | 강원대학교산학협력단 | 경구 투여용 나노입자 및 이의 제조방법 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE458505B (sv) * | 1979-07-10 | 1989-04-10 | Lepetit Spa | Anvaendningen av rifamycin sv och salter daerav foer framstaellning av en beredning foer behandling av reumatoid artrit samt vissa av salterna och deras framstaellning |
| US4409209A (en) * | 1979-10-12 | 1983-10-11 | Ciba-Geigy Corporation | Novel phosphorylmuramyl peptides and processes for the manufacture thereof |
| IT1230576B (it) | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
| IE61651B1 (en) | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
| IT1260505B (it) | 1992-06-01 | 1996-04-09 | Poli Ind Chimica Spa | Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon |
| CN1097306A (zh) * | 1993-07-12 | 1995-01-18 | 中国医科大学第二临床学院 | 复方抗炎栓剂 |
| US5849327A (en) * | 1994-07-29 | 1998-12-15 | Advanced Polymer Systems, Inc. | Delivery of drugs to the lower gastrointestinal tract |
| US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US6245351B1 (en) | 1996-03-07 | 2001-06-12 | Takeda Chemical Industries, Ltd. | Controlled-release composition |
| US5985823A (en) * | 1997-06-09 | 1999-11-16 | Ambi Inc. | Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
| SK180499A3 (en) * | 1997-07-01 | 2001-08-06 | Pfizer | Sertraline salts and sustained-release dosage forms of sertraline |
| DE19850445A1 (de) * | 1998-11-02 | 2000-05-04 | Falk Pharma Gmbh | Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| GB9910773D0 (en) | 1999-05-11 | 1999-07-07 | West Pharm Serv Drug Res Ltd | Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract |
| DK1183014T3 (da) * | 1999-06-14 | 2004-02-09 | Cosmo Spa | Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse |
| JP4393098B2 (ja) * | 2002-06-21 | 2010-01-06 | 独立行政法人科学技術振興機構 | アンサマイシン系抗生物質の新規用途及び新規血管新生抑制物質のスクリーニング方法 |
| CN1201736C (zh) * | 2002-07-19 | 2005-05-18 | 安徽省药物研究所 | 甲硝唑结肠定位缓释制剂 |
| NZ538998A (en) * | 2002-08-26 | 2007-12-21 | Sla Pharma Ag | Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
| WO2005030173A1 (en) | 2003-09-25 | 2005-04-07 | Ranbaxy Laboratories Limited | Colon-specific drug delivery using interpolymer complexations |
-
2004
- 2004-06-25 IT IT001295A patent/ITMI20041295A1/it unknown
-
2005
- 2005-05-03 CN CN2005800206291A patent/CN1976685B/zh not_active Expired - Lifetime
- 2005-05-03 EP EP07122775A patent/EP1894560A1/en not_active Withdrawn
- 2005-05-03 CN CNA2008101001129A patent/CN101317826A/zh active Pending
- 2005-05-03 RS RSP-2008/0241A patent/RS50581B/sr unknown
- 2005-05-03 AT AT05749954T patent/ATE392889T1/de active
- 2005-05-03 KR KR1020067027024A patent/KR101157486B1/ko not_active Expired - Lifetime
- 2005-05-03 US US11/571,044 patent/US8486446B2/en not_active Expired - Fee Related
- 2005-05-03 CA CA2569683A patent/CA2569683C/en not_active Expired - Lifetime
- 2005-05-03 SI SI200530254T patent/SI1763339T1/sl unknown
- 2005-05-03 WO PCT/EP2005/052025 patent/WO2006003043A1/en not_active Ceased
- 2005-05-03 ES ES05749954T patent/ES2303255T3/es not_active Expired - Lifetime
- 2005-05-03 JP JP2007517234A patent/JP5026262B2/ja not_active Expired - Lifetime
- 2005-05-03 DK DK05749954T patent/DK1763339T3/da active
- 2005-05-03 DE DE602005006278T patent/DE602005006278T2/de not_active Expired - Lifetime
- 2005-05-03 MX MXPA06014698A patent/MXPA06014698A/es active IP Right Grant
- 2005-05-03 HR HR20080252T patent/HRP20080252T3/xx unknown
- 2005-05-03 PT PT05749954T patent/PT1763339E/pt unknown
- 2005-05-03 EP EP05749954A patent/EP1763339B1/en not_active Expired - Lifetime
- 2005-05-03 ZA ZA200610577A patent/ZA200610577B/en unknown
- 2005-05-03 PL PL05749954T patent/PL1763339T3/pl unknown
- 2005-05-03 KR KR1020087012947A patent/KR20080059337A/ko not_active Withdrawn
- 2005-05-03 CA CA002628005A patent/CA2628005A1/en not_active Abandoned
-
2008
- 2008-02-20 JP JP2008039159A patent/JP2008163038A/ja not_active Withdrawn
- 2008-06-05 US US12/133,568 patent/US20080233193A1/en not_active Abandoned
- 2008-07-14 CY CY20081100739T patent/CY1108196T1/el unknown
-
2012
- 2012-04-19 US US13/451,111 patent/US8263120B2/en not_active Expired - Lifetime
- 2012-08-22 US US13/592,088 patent/US8741948B2/en not_active Expired - Lifetime
- 2012-08-22 US US13/592,097 patent/US20120316229A1/en not_active Abandoned
- 2012-09-14 US US13/616,582 patent/US8529945B2/en not_active Expired - Fee Related
-
2014
- 2014-08-28 US US14/471,509 patent/US20140370093A1/en not_active Abandoned
-
2019
- 2019-03-01 US US16/289,748 patent/US20190192441A1/en not_active Abandoned
- 2019-05-28 FI FIC20190031C patent/FIC20190031I1/fi unknown
- 2019-07-08 HU HUS1900037C patent/HUS1900037I1/hu unknown
-
2020
- 2020-12-07 US US17/114,057 patent/US20210093576A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20190031I1 (fi) | Rifamysiini SV | |
| DE602004008105D1 (de) | 42-o-alkoxyalkylrapamycinderivate und diese enthaltende zusammensetzungen | |
| MY150958A (en) | Compounds for the treatment of multi-drug resistant bacterial infections | |
| EP1824442A4 (en) | PHARMACEUTICAL AND THERAPEUTIC COMPOSITIONS FROM THE GARCINIA MANGOSTANA L PLANT | |
| LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
| PT2194049E (pt) | N-óxidos de derivados de n-fenil-2-pirimidina-amina | |
| ATE355065T1 (de) | Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika | |
| PT1401501E (pt) | Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo | |
| PL2878297T3 (pl) | Leki do leczenia lub zapobiegania chorobom zwłóknieniowym | |
| BR0311285A (pt) | composições e processos para revestimento de implantes médicos | |
| WO2008153762A3 (en) | S-nitrosothiol formulations and storage systems | |
| ATE415968T1 (de) | 3,11b-cis-dihydrotetrabanezin zur behandlung von schizophrenie und anderen psychosen | |
| ATE537828T1 (de) | Psychotropes mittel und nahrungsmittel zur förderung der gesundheit enthaltend neferin | |
| DE602005011240D1 (de) | Landwirtschaftliche desinfizierende Zusammensetzung enthaltend Hypochlorsäure und Streumittel | |
| WO2006116221A3 (en) | Therapeutic combinations for the treatment or prevention of psychotic disorders | |
| ATE554753T1 (de) | 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia | |
| WO2007076053A8 (en) | Stable s-nitrosothiol formulations | |
| CL2007003281A1 (es) | Compuesto 1-(4-metilfenil)dihidro-1h-pirrolo[1,2-a]imidazol-2,5-(3h,6h)-diona; composicion farmaceutica; y uso para el tratamiento terapeutico o preventivo de la neurotoxicidad periferica inducida por quimioterapeuticos. | |
| ITMI20051231A1 (it) | Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale | |
| EA200601368A1 (ru) | Макролиды, обладающие противовоспалительной активностью | |
| ATE511512T1 (de) | Olanzapinpamoat-dihydrat | |
| ITBO20050416A1 (it) | Composizione per la cura e/o la prevenzione di attacchi da parte di agenti biologici | |
| DK1827496T3 (da) | Orale behandlingssammensætninger indeholde et antiadhæsionsmiddel, et antibakterielt middel og en inkompatibel forbindelse | |
| PL1612210T3 (pl) | Nowe analogi nitrobenzylotioinozyny | |
| CL2004000753A1 (es) | Compuestos derivados de oxazolidinona y/o isoxazolina, composicion farmaceutica, procedimiento de preparacion, utiles como antibacterianos. |